Technology | November 20, 2009

New Balloon Catheter Aids Endoprosthesis for Aortic Repair

November 18, 2009 – As part of a new partnership deal with QXMédical LLC, W. L. Gore & Associates will distribute the Q50 Stent Graft Balloon Catheter, which is designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA).

The U.S. Food and Drug Administration (FDA) cleared the catheter in October 2009. This partnership allows Gore to provide customers with a balloon catheter for modeling and occlusion use with the GORE EXCLUDER AAA Endoprosthesis and all other aortic stent grafts.

Gore said the Q50 Stent Graft Balloon Catheter complements the GORE EXCLUDER AAA Endoprosthesis for facilitating endovascular aneurysm repair.

The QXMédical device is a full occlusion balloon catheter that helps aortic stent grafts to fully expand and seal in vessel diameters ranging from 10–50 mm. It offers a short, flexible tip that increases trackability through challenging anatomy, and a compliant polyurethane balloon that inflates and deflates rapidly to give physicians more control. The maker said the Q50 Stent Graft Balloon Catheter offers the broadest inflation diameter range available on the market and is compatible with standard 0.035-inch guide wires and low-profile 12 Fr. introducer sheaths. With 65 and 100 cm length pushable catheter shafts in an 8 Fr. diameter, the device accommodates both abdominal and thoracic applications.

For more information:,

Related Content

Edwards Lifesciences Recalls IntraClude Intra-aortic Occlusion Device
News | Balloon Catheter | July 15, 2019
Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during...
Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init